These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 34019900)
1. Overview of key molecular and pharmacological targets for diabetes and associated diseases. Shahcheraghi SH; Aljabali AAA; Al Zoubi MS; Mishra V; Charbe NB; Haggag YA; Shrivastava G; Almutary AG; Alnuqaydan AM; Barh D; Dua K; Chellappan DK; Gupta G; Lotfi M; Serrano-Aroca Á; Bahar B; Mishra YK; Takayama K; Panda PK; Bakshi HA; Tambuwala MM Life Sci; 2021 Aug; 278():119632. PubMed ID: 34019900 [TBL] [Abstract][Full Text] [Related]
2. Role of silibinin in the management of diabetes mellitus and its complications. Chu C; Li D; Zhang S; Ikejima T; Jia Y; Wang D; Xu F Arch Pharm Res; 2018 Aug; 41(8):785-796. PubMed ID: 29978427 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic strategies for diabetes and complications: a role for sphingolipids? Fox TE; Kester M Adv Exp Med Biol; 2010; 688():206-16. PubMed ID: 20919656 [TBL] [Abstract][Full Text] [Related]
4. Mining the Genome for Therapeutic Targets. Florez JC Diabetes; 2017 Jul; 66(7):1770-1778. PubMed ID: 28603140 [TBL] [Abstract][Full Text] [Related]
5. Inflammasome as a New Therapeutic Target for Diabetic Complications. Volpe CM; Anjos PM; Nogueira-Machado JA Recent Pat Endocr Metab Immune Drug Discov; 2016; 10(1):56-62. PubMed ID: 26899852 [TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in diabetes and diabetes-associated complications. Lorenzen J; Kumarswamy R; Dangwal S; Thum T RNA Biol; 2012 Jun; 9(6):820-7. PubMed ID: 22664916 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of curcumin in diabetic complications. Parsamanesh N; Moossavi M; Bahrami A; Butler AE; Sahebkar A Pharmacol Res; 2018 Oct; 136():181-193. PubMed ID: 30219581 [TBL] [Abstract][Full Text] [Related]
8. MicroRNAs as therapeutic targets for the treatment of diabetes mellitus and its complications. Regazzi R Expert Opin Ther Targets; 2018 Feb; 22(2):153-160. PubMed ID: 29257914 [TBL] [Abstract][Full Text] [Related]
9. Experimental evidence for curcumin and its analogs for management of diabetes mellitus and its associated complications. Rivera-Mancía S; Lozada-García MC; Pedraza-Chaverri J Eur J Pharmacol; 2015 Jun; 756():30-7. PubMed ID: 25769841 [TBL] [Abstract][Full Text] [Related]
10. Targeting orphan G protein-coupled receptors for the treatment of diabetes and its complications: C-peptide and GPR146. Kolar GR; Grote SM; Yosten GL J Intern Med; 2017 Jan; 281(1):25-40. PubMed ID: 27306986 [TBL] [Abstract][Full Text] [Related]
11. Past and current perspective on new therapeutic targets for Type-II diabetes. Patil PD; Mahajan UB; Patil KR; Chaudhari S; Patil CR; Agrawal YO; Ojha S; Goyal SN Drug Des Devel Ther; 2017; 11():1567-1583. PubMed ID: 28579755 [TBL] [Abstract][Full Text] [Related]
12. Emerging Targets for Therapeutic Development in Diabetes and Its Complications: The RAGE Signaling Pathway. Litwinoff E; Hurtado Del Pozo C; Ramasamy R; Schmidt AM Clin Pharmacol Ther; 2015 Aug; 98(2):135-44. PubMed ID: 25974754 [TBL] [Abstract][Full Text] [Related]
13. Role of platelet-derived growth factor in type II diabetes mellitus and its complications. Shen S; Wang F; Fernandez A; Hu W Diab Vasc Dis Res; 2020; 17(7):1479164120942119. PubMed ID: 32744067 [TBL] [Abstract][Full Text] [Related]
15. Histamine in diabetes: Is it time to reconsider? Pini A; Obara I; Battell E; Chazot PL; Rosa AC Pharmacol Res; 2016 Sep; 111():316-324. PubMed ID: 27343700 [TBL] [Abstract][Full Text] [Related]
16. The role of natriuretic peptides in diabetes and its complications. Feng Y; Wang D; Bi H; Zhang H Biomed Pharmacother; 2016 Dec; 84():1826-1832. PubMed ID: 27832993 [TBL] [Abstract][Full Text] [Related]
17. Coumarins as potential antidiabetic agents. Li H; Yao Y; Li L J Pharm Pharmacol; 2017 Oct; 69(10):1253-1264. PubMed ID: 28675434 [TBL] [Abstract][Full Text] [Related]
18. A new research hot spot: The role of NLRP3 inflammasome activation, a key step in pyroptosis, in diabetes and diabetic complications. Yu ZW; Zhang J; Li X; Wang Y; Fu YH; Gao XY Life Sci; 2020 Jan; 240():117138. PubMed ID: 31809715 [TBL] [Abstract][Full Text] [Related]
19. The current and future perspectives of zinc oxide nanoparticles in the treatment of diabetes mellitus. Tang KS Life Sci; 2019 Dec; 239():117011. PubMed ID: 31669241 [TBL] [Abstract][Full Text] [Related]
20. Targeting AMPK in Diabetes and Diabetic Complications: Energy Homeostasis, Autophagy and Mitochondrial Health. Madhavi YV; Gaikwad N; Yerra VG; Kalvala AK; Nanduri S; Kumar A Curr Med Chem; 2019; 26(27):5207-5229. PubMed ID: 29623826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]